AKT1 and central nervous system cancer: Sodium butyrate inhibits glioma cell growth in vitro, arrests the cell cycle, and enhances PD-L1 expression in glioma cells by activating the PI3K/AKT pathway, which may facilitate the conversion of gliomas from ‘cold’ tumors to ‘hot’ tumors.